Personalized [177Lu]Lutetium-PSMA Therapy for Patients with Pre-Treated Castration-Resistant Prostate Cancer: A Single Institution Experience from a Comprehensive Cancer Centre.

Thaiss, Wolfgang; Zengerling, Friedemann; Friedrich, Julia; Hechler, Veronika; Grunert, Michael; Bolenz, Christian; Wiegel, Thomas; Beer, Ambros J; Prasad, Vikas

Thaiss, Wolfgang; Zengerling, Friedemann; Friedrich, Julia; Hechler, Veronika; Grunert, Michael; Bolenz, Christian; Wiegel, Thomas; Beer, Ambros J; Prasad, Vikas.

Afiliación

Thaiss W; Department of Nuclear Medicine, University Hospital Ulm, 89081 Ulm, Germany.
Zengerling F; Department of Diagnostic and Interventional Radiology, University Hospital Ulm, 89081 Ulm, Germany.
Friedrich J; Surgical Oncology Ulm, i2SOUL Consortium, 89075 Ulm, Germany.
Hechler V; Surgical Oncology Ulm, i2SOUL Consortium, 89075 Ulm, Germany.
Grunert M; Department of Urology and Pediatric Urology, University Hospital Ulm, 89081 Ulm, Germany.
Bolenz C; Department of Nuclear Medicine, University Hospital Ulm, 89081 Ulm, Germany.
Wiegel T; Department of Urology and Pediatric Urology, University Hospital Ulm, 89081 Ulm, Germany.
Beer AJ; Department of Nuclear Medicine, University Hospital Ulm, 89081 Ulm, Germany.
Prasad V; Department of Nuclear Medicine, German Armed Forces Hospital of Ulm, 89081 Ulm, Germany.

Cancers (Basel) ; 15(12)2023 Jun 16.

Article en En | MEDLINE | ID: mdl-37370826

Palabras clave

PSA response; castration-resistant prostate cancer; lutetium PSMA; prediction; radioligand therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google